Back in February, biotech firm Valneva SE’s proposed Covid-19 vaccine was touted by Boris Johnson’s government as a key plank of its ambitious, whatever-it-takes race to immunise the Brits. The UK had poured millions of pounds into Valneva’s Scottish factory, secured an extra 40 million vaccine doses on top of the 60 million it had already agreed to buy, and ...

There’s not a more important economic imperative for the US than the transition to renewable energy. Ominously, anti-development forces — commonly known as NIMBYs — threaten to make this transition much harder. And much of that NIMBY energy is coming from the political left. Consider the recent blockage of a solar power plant near Las Vegas. The Battle Born Solar ...

The European Central Bank (ECB) has made a very small down payment on a prolonged economic recovery, one durable enough to withstand Covid-19’s troubling variants and any other pandemic developments. But the big decision-making comes in December, when the central bank undertakes a comprehensive review of its bond-buying program, with a few more months of delta under its belt and ...